| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/26/2010 | CA2294703C Plasmids for plant transformation and method for using the same |
| 01/26/2010 | CA2256773C System and process for carrying out and monitoring polymerase chain reaction |
| 01/26/2010 | CA2230033C Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 01/26/2010 | CA2204666C Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 01/26/2010 | CA2188279C Interleukin-15 receptors |
| 01/26/2010 | CA2159043C Method of quantitating genomic dna |
| 01/26/2010 | CA2157667C Enzymes with xylanase activity from aspergillus aculeatus |
| 01/21/2010 | WO2010009465A2 Htlv-ii vector and methods of use |
| 01/21/2010 | WO2010009404A2 Markers associated with soybean rust resistance and methods of use therefor |
| 01/21/2010 | WO2010009353A1 Methods and vectors for producing transgenic plants |
| 01/21/2010 | WO2010009348A2 Transformation of glycerol and cellulosic materials into high energy fuels |
| 01/21/2010 | WO2010009203A2 Lateral flow nucleic acid detector |
| 01/21/2010 | WO2010008809A2 Compositions and methods for early stage sex determination |
| 01/21/2010 | WO2010008764A1 Pseudomonas fluorescens strains for production of extracellular recombinant protein |
| 01/21/2010 | WO2010008690A1 Methods for systematic control of protein stability |
| 01/21/2010 | WO2010008588A2 Modulation of gm98 (mrf) in remyelination |
| 01/21/2010 | WO2010008587A2 A viral nucleocapsid protein as a multifunctional translation initiation factor and increased protein and polypeptide production using same |
| 01/21/2010 | WO2010008582A2 Phagocytic cell drug delivery system |
| 01/21/2010 | WO2010008564A2 Plaice dna transposon system |
| 01/21/2010 | WO2010008563A2 Methods and systems for manipulating particles using a fluidized bed |
| 01/21/2010 | WO2010008562A2 Methods and materials for producing transgenic animals |
| 01/21/2010 | WO2010008543A2 Molecular signatures for diagnosing scleroderma |
| 01/21/2010 | WO2010008436A1 Methods and compositions for inhibition of bcl6 repression |
| 01/21/2010 | WO2010008204A2 Genes for enhancing resistance to magnaporthe oryzae and uses thereof |
| 01/21/2010 | WO2010008100A1 Method for induction of skeletal muscle cell or osteocyte |
| 01/21/2010 | WO2010008084A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | WO2010008075A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 01/21/2010 | WO2010008071A1 Method for screening of gene mutation by utilizing quantification technique |
| 01/21/2010 | WO2010008054A1 Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
| 01/21/2010 | WO2010008051A1 Anti-human clcp1 antibody and use thereof |
| 01/21/2010 | WO2010008044A1 Novel protein having endoglucanase activity, dna of the protein, and use of the same |
| 01/21/2010 | WO2010008010A1 Hcv/gbv-b chimeric virus |
| 01/21/2010 | WO2010008001A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | WO2010007797A1 Highly active shrna and method for production thereof |
| 01/21/2010 | WO2010007791A1 Ect2 oncogene as a therapeutic target and prognostic indicator for lung and esophageal cancer |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2010007701A1 Therapeutic agent and test agent for disease with myocardial necrosis |
| 01/21/2010 | WO2010007622A2 Long-acting interferons and derivatives thereof and methods thereof |
| 01/21/2010 | WO2010007522A1 Rna antagonists targeting gli2 |
| 01/21/2010 | WO2010007372A1 Transgenic rodent expressing truncated disc1 |
| 01/21/2010 | WO2010007365A1 Immunotherapeutic method |
| 01/21/2010 | WO2010007246A1 Self-replicating vector lacking an antibiotic-resistance gene |
| 01/21/2010 | WO2010007144A2 New mutated netrin 4 proteins, fragments thereof and their uses as drugs |
| 01/21/2010 | WO2010007035A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/21/2010 | WO2010006973A2 Compositions and methods for inhibiting expression of tgf-beta receptor genes |
| 01/21/2010 | WO2010006804A1 Method to obtain transgenic plants resistant to phytopathogen attack based on rna interference (rnai) |
| 01/21/2010 | WO2010006732A2 Brassica plant comprising a mutant indehiscent allelle |
| 01/21/2010 | WO2010006703A1 G-protein coupled receptor 30 (gpr30) knockout mice as a model for cardiovascular diseases |
| 01/21/2010 | WO2010006507A1 Life information field guiding apparatus |
| 01/21/2010 | WO2010006501A1 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders field of the invention |
| 01/21/2010 | WO2010006482A1 A multipurpose micro electric field networking cell processing device |
| 01/21/2010 | WO2010006454A2 Functionalized polypeptides |
| 01/21/2010 | WO2010006452A1 New influenza virus immunizing epitope |
| 01/21/2010 | WO2010006447A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 01/21/2010 | WO2010006446A1 Modified family 6 glycosidases with altered substrate specificity |
| 01/21/2010 | WO2010006415A1 Mammalian cell expression vectors and utilization |
| 01/21/2010 | WO2010006377A1 Therapeutic agents |
| 01/21/2010 | WO2010006373A1 High fructan cereal plants |
| 01/21/2010 | WO2009145840A3 Cellular production of hydroxyvalerates from levulinate |
| 01/21/2010 | WO2009145836A3 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 01/21/2010 | WO2009145489A3 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component |
| 01/21/2010 | WO2009143495A3 Saccharomyces cerevisiae strains for the overproduction of formate |
| 01/21/2010 | WO2009142767A9 Lentivector-based protein production |
| 01/21/2010 | WO2009139004A3 Tat dna sequences, gene constructs, vaccine and processes thereof |
| 01/21/2010 | WO2009135810A8 Plants having enhanced yield-related traits and a method for making the same |
| 01/21/2010 | WO2009132220A3 Isoprene synthase variants for improved microbial production of isoprene |
| 01/21/2010 | WO2009131365A3 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer |
| 01/21/2010 | WO2009130612A3 Prion epitopes and methods of use thereof |
| 01/21/2010 | WO2009128056A3 A method for screening compounds comprising the use of picornavirus protease 2a |
| 01/21/2010 | WO2009125992A3 Vector for transformation using transposons, microorganisms transformed by the vector, and method for producing l-lysine using the same |
| 01/21/2010 | WO2009124044A3 Tumor growth inhibition via conditioning of tumor microenvironment |
| 01/21/2010 | WO2009120895A3 Recombinant bacteriophages useful for tissue engineering |
| 01/21/2010 | WO2009114614A3 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 01/21/2010 | WO2009108941A3 Production and use of plant degrading materials |
| 01/21/2010 | WO2009108217A3 Compositions comprising k-ras sirna and methods of use |
| 01/21/2010 | WO2009102878A3 Method for archiving and clonal expansion |
| 01/21/2010 | WO2009102421A3 Targeted therapeutics based on engineered proteins that bind egfr |
| 01/21/2010 | WO2009095899A8 Hybrids of saccharomyces cerevisiae and torulaspora delbrueckii, use thereof to conduct red and white wine fermentation and/or to restart stuck or sluggish fermentation, and process of obtaining such hybrids |
| 01/21/2010 | WO2009016232A8 Plants having enhanced yield-related traits and a method for making the same |
| 01/21/2010 | WO2008154695A8 Method for improving stress resistance in plants and materials therefor |
| 01/21/2010 | WO2008146251A9 A primary micro rna expression cassette |
| 01/21/2010 | WO2007095304A3 Production of foreign nucleic acids and polypeptides in plant systems |
| 01/21/2010 | WO2005074521A9 C-TERMINAL p53 PALINDROMIC PEPTIDE THAT INDUCES APOPTOSIS OF CELLS WITH ABERRANT p53 AND USES THEREOF |
| 01/21/2010 | WO2004056961A9 Methods of identifying compounds that modulate protein activity |
| 01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2003106635A9 Functional sites |
| 01/21/2010 | WO2003057859A9 Genes for altering mitochondrial function and for hybrid seed production |
| 01/21/2010 | WO2003006624A9 47619 and 47621, human ion channels, and uses thereof |
| 01/21/2010 | WO2003006609A9 Human cytokine receptor |
| 01/21/2010 | US20100017919 Rice Gene, GS3, Exerting Primary Control Over Grain Length and Grain Weight |
| 01/21/2010 | US20100017918 Arabidopsis derived promoters for regulation of plant expression |
| 01/21/2010 | US20100017917 Transgenic plants with tocopherol methyltransferase |
| 01/21/2010 | US20100017915 Manipulation of Plant Polysaccharide Synthases |
| 01/21/2010 | US20100017914 Insecticidal proteins |
| 01/21/2010 | US20100017913 Disease resistant plants |
| 01/21/2010 | US20100017912 Compositions and methods using rna interference of cad-like genes for control of nematodes |